A third class of anti‐arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474
Open Access
- 1 August 1970
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 39 (4), 675-687
- https://doi.org/10.1111/j.1476-5381.1970.tb09893.x
Abstract
1 Both MJ 1999 and AH 3474 protected guinea-pigs anaesthetized with urethane against ouabain-induced ventricular fibrillation. 2 MJ 1999 had 1/90, and AH 3474 1/30, of the activity of procaine in reducing the height of the action potential of frog sciatic nerve. 3 MJ 1999 and AH 3474 reduced the rate of rise of intracellularly recorded action potentials at concentrations in excess of 160 × 10−6m (50 mg/l.). It was concluded that direct depression of depolarization could have contributed little to the protection against ouabain-induced fibrillation. 4 MJ 1999, but not AH 3474, greatly prolonged the duration of the action potential in acute experiments on isolated atrial and ventricular muscle, and prolonged the Q-Tc interval of the electrocardiogram in anaesthetized guinea-pigs. It is suggested that this effect contributes to anti-arrhythmic activity. 5 At concentrations up to 80 × 10−6m AH 3474 had positive chronotropic and inotropic effects on isolated rabbit atrial muscle, but at higher concentrations these were superseded by negative effects. MJ 1999 was depressant at all concentrations studied, the threshold concentrations being 19 × 10−6m for chronotropic, and 162 × 10−6m for inotropic effects.Keywords
This publication has 39 references indexed in Scilit:
- Effects of sotalol and propranolol administered orally in manEuropean Journal of Pharmacology, 1969
- The pharmacology of 5-(2-t-butylamino-1-hydroxyethyl) salicylamide (AH 3474), a β-adrenoreceptor blocking agentJournal of Pharmacy and Pharmacology, 1969
- A comparative study of some cardiovascular effects of sotalol (MJ 1999) and propranololLife Sciences, 1969
- Sotalol: A new, safe beta adrenergic receptor blocking agent∗The American Journal of Cardiology, 1968
- Propranolol, MJ 1999 and Ciba 39089 Ba in ouabain and adrenaline induced cardiac arrhythmiasEuropean Journal of Pharmacology, 1968
- Myocardial and local anesthetic actions of β-adrenergic receptor blocking drugs: Relationship to physicochemical propertiesEuropean Journal of Pharmacology, 1968
- Comparative Actions of Beta-Adrenergic Receptor Blocking Drugs on the Contractile and Electrical Properties of Isolated Human Atrial MuscleCardiology, 1968
- EVALUATION OF THE CARDIAC EFFECTS OF SEVERAL BETA ADRENERGIC BLOCKING AGENTSAnnals of the New York Academy of Sciences, 1967
- THE STRUCTURE‐ACTIVITY RELATIONSHIPS OF BETA ADRENERGIC DRUGS AND BETA ADRENERGIC BLOCKING DRUGSAnnals of the New York Academy of Sciences, 1967
- Effect of Tetrodotoxin on Membrane Currents in Mammalian Cardiac FibresNature, 1967